Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit your nominations for the Fierce CRO Awards
Alzheimer's disease
Biotech
Cassava stops Alzheimer's program as simufilam fails again
Months after seeing one phase 3 trial fail, the biotech plans to stop development altogether after chalking up another late-stage flop.
Nick Paul Taylor
Mar 25, 2025 9:12am
Oligomerix small molecule tamps down tau tangles in mice
Mar 14, 2025 12:30pm
Samsung backs Alzheimer's blood test developer C2N Diagnostics
Mar 13, 2025 12:15pm
2024's top 10 clinical trial flops
Feb 18, 2025 3:00am
Eli Lilly lops Alzheimer's and obesity assets from pipeline
Feb 6, 2025 9:16am
Analysts 'highly encouraged' by Vigil's phase 1 Alzheimer's data
Jan 23, 2025 9:51am
